"千代田区 御茶ノ水 内科 リウマチ科 消化器外科 婦人科 放射線科 整形外科 泌尿器科 循環器内科 肝臓内科 乳腺外科 皮膚科 腫瘍内科 麻酔科 リハビリテーション科 病理診断科 糖尿病内科 脳神経内科 PDT がん 緩和ケア 地域包括ケア 紹介状不要 PCR検査（自費診療・無症状/海外渡航目的） 9価HPVワクチン（子宮頸がん予防）"

During the past decade, Sasaki Foundation Kyoundo Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sasaki Foundation Kyoundo Hospital" are "Hepatocellular Carcinoma" (1 trials), "Hepatocellular Carcinoma (HCC)" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Sasaki Foundation Kyoundo Hospital" in a lesser frequency.

Most popular intervention types in "Sasaki Foundation Kyoundo Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Axitinib (AG-013736)" (1 trials), "Best Supportive Care" (1 trials), "CP-690,550" (1 trials), "Placebo" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sasaki Foundation Kyoundo Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Sasaki Foundation Kyoundo Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sasaki Foundation Kyoundo Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sasaki Foundation Kyoundo Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".